Skip navigation

Search results for the

Showing 151 to 165 of 497 results

Winners of the HCPC student competition 2024 announced

Find out who won the HCPC student competition 2024, which asked students to design a learning session about social media. 

Working upstream to ensure education providers meet our high regulatory standards

We take a flexible approach when undertaking our education quality assurance assessment activities, aiming to be ‘right touch’ in our regulatory activities.

HCPC launches a public workshop on developing its corporate strategy

We’re looking to understand how future changes might affect our work, and the work of those we regulate. We're running a workshop open to the general public and our stakeholders this September.

Reclassification of gabapentin and pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

New and updated Partner policies

We regularly review our policies to ensure that they are fit for purpose.

HCPC unites with health regulators to issue joint statement in support of reflective practice across healthcare

Nine healthcare regulators, including the HCPC, have signed a joint statement outlining the processes and advantages of good reflective practice

HCPC fee consultation 2026

The HCPC Council met on 26 March 2026 and agreed to consult on a proposed fee rise of £5.06 to the annual registration fee and equivalent increases in our other fees.

Performance review requirements 2024-25 - what to expect

We emailed education providers due their performance review in 2023-24 in late June. Providers who will undergo the process this year (2023-24) will have been given specific requirements and a key contact to work with at the HCPC.